UAB Study Finds CBD Oil Helps Epilepsy Patients
Researchers at UAB published a study this month that offers hope to those dealing with severe epilepsy. It found cannabidiol, or CBD oil, helps curb seizures. The substance is derived from marijuana, minus the hallucinogenic properties. The study was conducted under a 2014 Alabama law known as “Carly’s Law,” which authorized UAB to research CBD oil.
The study found CBD oil reduced the frequency of seizures by about two-thirds. It also reduced the severity of seizures. Study participants had fewer side effects when looking at their medications overall.
“We don’t know whether this is an effect of cannabidiol or whether this is the effect of slightly decreasing other medications or if there is something else, but it’s a very significant finding,” said Dr. Jerzy Szaflarski, director of UAB’s Epilepsy Center.
Advocates, particularly parents of children with severe epilepsy, have contended CBD oil helps with seizures. Szaflarski says a growing body of research like the UAB study backs that up.
The drug used in the study is called Epidiolex and in July the Food and Drug Administration approved it for two rare types of epilepsy. It’s the first CBD-based drug approved by federal regulators. Robert Speth, pharmaceutical sciences professor at Nova Southeastern University in Florida, says that represents a slight softening in attitude by the feds toward marijuana, although there are still tight restrictions on medical research of marijuana.
“You have to keep it in a locked safe. You have to have two layers of security,” Speth says. “It makes it very cumbersome.”
Epidiolex could hit the market next year and with a big price tag – $32,500 a year. Patients won’t necessarily pay that amount as insurers could shoulder some of that cost. A spokeswoman for Alabama’s largest insurer, Blue Cross and Blue Shield of Alabama, says they’ll review the drug’s effectiveness and safety before deciding whether to cover it.
Q&A: A former New Orleans police chief says it’s time the U.S. changes its marijuana policy
Ronal Serpas is one of 32 law enforcement leaders who signed a letter sent to President Biden in support of moving marijuana to a Schedule III drug.
How food stamps could play a key role in fixing Jackson’s broken water system
JXN Water's affordability plan aims to raise much-needed revenue while offering discounts to customers in need, but it is currently tied up in court.
Alabama mine cited for federal safety violations since home explosion led to grandfather’s death, grandson’s injuries
Following a home explosion that killed one and critically injured another, residents want to know more about the mine under their community. So far, their questions have largely gone unanswered.
Crawfish prices are finally dropping, but farmers and fishers are still struggling
Last year’s devastating drought in Louisiana killed off large crops of crawfish, leading to a tough season for farmers, fishers and seafood lovers.
Lawmakers consider medical cannabis revamp
It’s been three years since Alabama lawmakers passed legislation establishing a system to govern medical cannabis in the state, yet not one prescription for the drug has been filled. The rollout has been delayed by lawsuits and conflict over the licensing process.
Man arrested in connection with device that exploded outside Alabama attorney general’s office
Kyle Benjamin Douglas Calvert, 26, of Irondale, Alabama, was arrested Wednesday on charges of malicious use of an explosive and possession of an unregistered destructive device, the U.S. attorney’s office said.
